Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress

Applied Skills Session 3507

How to Measure Cognitive Impairment

Tuesday, October 6, 2026
16:30 - 18:00 | Conference Room E5, Level 3

In this session faculty will present clinical clues for diagnosing cognitive symptoms and monitoring cognitive decline at bedside. They will review the appropriate tests for evaluating different aspects and extent of cognitive decline. In addition, they will review newer means of assessing and monitoring cognition including digital health technologies and various biomarkers.

Moderator(s):

Harini Sarva, USA

Presenters:

Adeline Ng, Singapore

CSPC Liaison(s):

Harini Sarva, USA

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Recognize clinical clues and best tests for evaluating cognitive decline during routine clinic visits
  2. Identify new tools including digital measures and biomarkers to accurately diagnose cognitive decline

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)

Education Level

Beginner / Foundational
Intermediate / Experienced